Fairvalue-Calculator Fairvalue-Calculator
EN DE

Aptamer Sciences Inc (291650) Fair Value & Analysis

Healthcare · KR · Market cap 51.8B KRW

Price752.00 KRW
Fair Value212.82 KRW
Upside-71.7%
Quality95/100
Evidence: Low Range 140.46 KRW – 266.03 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Aptamer Sciences Inc (291650) currently trades at 752.00 KRW, while our model-based Fair Value estimate is 212.82 KRW — implying the stock looks roughly 71.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. Aptamer Sciences Inc was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Aptamer Sciences Inc (291650) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 212.82 KRW versus a price of 752.00 KRW — about −72% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 291650?
Our 21-model fair value for Aptamer Sciences Inc is 212.82 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 752.00 KRW.
What is the quality score of 291650?
Aptamer Sciences Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.